CCL27



CCL27

L1LL1P2PP2L3LL3P4PP4S5SS5S6SS6T7TT7S8SS8C9CC9C10CC10T11TT11Q12QQ12L13LL13Y14YY14R15RR15Q16QQ16P17PP17L18LL18P19PP19S20SS20R21RR21L22LL22L23LL23R24RR24R25RR25I26II26V27VV27H28HH28M29MM29E30EE30L31LL31Q32QQ32E33EE33A34AA34D35DD35G36GG36D37DD37C38CC38H39HH39L40LL40Q41QQ41A42AA42V43VV43V44VV44L45LL45H46HH46L47LL47... and 48 more residue(s)...... and 48 more residue(s)

SMILES None
InChIKey None
Sequence LPLPSSTSCCTQLYRQPLPSRLLRRIVHMELQEADGDCHLQAVVLHLARRSVCVHPQNRSLARWLERQGKRLQGTVPSLNLVLQKKMYSHPQQQN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL27

L1LL1P2PP2L3LL3P4PP4S5SS5S6SS6T7TT7S8SS8C9CC9C10CC10T11TT11Q12QQ12L13LL13Y14YY14R15RR15Q16QQ16P17PP17L18LL18P19PP19S20SS20R21RR21L22LL22L23LL23R24RR24R25RR25I26II26V27VV27H28HH28M29MM29E30EE30L31LL31Q32QQ32E33EE33A34AA34D35DD35G36GG36D37DD37C38CC38H39HH39L40LL40Q41QQ41A42AA42V43VV43V44VV44L45LL45H46HH46L47LL47... and 48 more residue(s)...... and 48 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.